Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Untreated Metastatic Colorectal Cancer”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Testing effectiveness (Phase 2)Ended earlyNCT00037180
What this trial is testing

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Who this might be right for
Neoplasm MetastasisColorectal Neoplasms
Pfizer 212
Early research (Phase 1)Study completedNCT00026364
What this trial is testing

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT00459901
What this trial is testing

Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Peter Kozuch 13
Testing effectiveness (Phase 2)Study completedNCT00483834
What this trial is testing

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University Health Network, Toronto 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04607421
What this trial is testing

Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Pfizer 841
Testing effectiveness (Phase 2)Study completedNCT00439517
What this trial is testing

Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.

Who this might be right for
Previously Untreated Metastatic Colorectal Cancer
Merck KGaA, Darmstadt, Germany 302
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00873756
What this trial is testing

Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT01516216
What this trial is testing

Study of Vitamin D in Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Dana-Farber Cancer Institute 139
Testing effectiveness (Phase 2)Study completedNCT00444678
What this trial is testing

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
NYU Langone Health 36
Testing effectiveness (Phase 2)Study completedNCT01374425
What this trial is testing

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 376
Large-scale testing (Phase 3)Study completedNCT02776683
What this trial is testing

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 123
Testing effectiveness (Phase 2)Study completedNCT01399684
What this trial is testing

A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 127
Testing effectiveness (Phase 2)Study completedNCT00819780
What this trial is testing

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+1 more
Amgen 285
Testing effectiveness (Phase 2)Study completedNCT01652196
What this trial is testing

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
John Hays 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05217446
What this trial is testing

Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Pfizer 108
Testing effectiveness (Phase 2)Ended earlyNCT00506168
What this trial is testing

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsSecondaryDrug Therapy, Combination
National Cancer Center, Korea 37
Large-scale testing (Phase 3)Ended earlyNCT00070122
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 2,200
Large-scale testing (Phase 3)Looking for participantsNCT07221357
What this trial is testing

Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Who this might be right for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb 990
Early research (Phase 1)Study completedNCT00920868
What this trial is testing

XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib

Who this might be right for
Solid TumorMetastatic Colorectal Cancer
Herbert Hurwitz, MD 22
Next Page